Yong Chen
Anyang Hospital of Traditional Chinese Medicine(CN)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Fungal Biology and Applications, Microbial Natural Products and Biosynthesis, Epigenetics and DNA Methylation, Cancer-related molecular mechanisms research
Most-Cited Works
- → NVP-BEZ235, a novel dual PI3K–mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells(2015)115 cited
- → Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cellsin vitroandin vivo(2015)101 cited
- → Imp2 regulates GBM progression by activating IGF2/PI3K/Akt pathway(2015)89 cited
- → Berberine Attenuates Cholesterol Accumulation in Macrophage Foam Cells by Suppressing AP-1 Activity and Activation of the Nrf2/HO-1 Pathway(2019)80 cited
- → Resveratrol Suppresses Epithelial-Mesenchymal Transition in GBM by Regulating Smad-Dependent Signaling(2019)73 cited
- → Temozolomide in combination with metformin act synergistically to inhibit proliferation and expansion of glioma stem-like cells(2016)54 cited
- → An Intelligent Nanoplatform for Orthotopic Glioblastoma Therapy by Nonferrous Ferroptosis(2022)53 cited
- → RETRACTED ARTICLE: Newcastle disease virus enhances the growth-inhibiting and proapoptotic effects of temozolomide on glioblastoma cells in vitro and in vivo(2018)52 cited
- → Ginsenoside Rg1 attenuates protein aggregation and inflammatory response following cerebral ischemia and reperfusion injury(2019)51 cited
- → β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species(2018)50 cited